CTOs on the Move

Ovid Therapeutics

www.ovidrx.com

 
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ovidrx.com
  • 1460 Broadway
    New York, NY USA 10036
  • Phone: 646.661.7661

Executives

Name Title Contact Details
Stephanie Licata
VP, Program Leadership & Portfolio Management Profile

Funding

Ovid Therapeutics raised $75M on 08/11/2015
Ovid Therapeutics raised $25.86M on 01/23/2017
Ovid Therapeutics raised $25M on 02/26/2019
Ovid Therapeutics raised $20M on 02/26/2019

Similar Companies

American Association of Nuerological Surgeons

American Association of Nuerological Surgeons is a Rolling Meadows, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuroLogica Corporation

NeuroLogica Corporation is a Danvers, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Union Printers Home

Union Printers Home is a Colorado Springs, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nursefinders

Nursefinders is one of the nation's largest medical staffing and specialty home health care companies providing RNs, LPN/LVNs, therapists, nursing assistants, home health aides, companions and other health care and medical clerical professionals. We

Polyvue Technologies

Polyvue Technologies is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.